Additionally, the pooled results show that CRP is greatly related to the shortening of DPS among patients suffering from osteosarcoma (HR = 2.76, 95% CI: 2.01-3.80, P < 0.0001; I2 = 0.0%, P = 0.549; Figure 3). This evidence concerns the gene CRP and osteosarcoma.